In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tom Ross, President and CEO at Grand River Aseptic Manufacturing (GRAM).

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tom, covering:

• How a passive investment in a small growing business led to running one of the most reputable CDMOs in the US

During his career, Tom has held senior executive roles at a large, publicly held pharmaceutical company and at leading, smaller entrepreneurial organizations. He spent eight years at Perrigo Company, a multi-billion-dollar generic and OTC pharmaceutical company, where he served on the executive committee and led the financial team. Tom left Perrigo to help set up the processes, systems and infrastructure for two smaller, high-growth companies. He also served as managing director at DWH, LLC, a consulting company focused on helping emerging businesses maximize value.

Tom, who joined GRAM in 2013, received his Bachelors in Accounting from Michigan State University and completed coursework for an MBA at the University of Miami. As President and Chief Executive Officer at GRAM, Tom Ross uses his extensive managerial and technical expertise to create a culture where employees can maximize their performance. A skilled communicator, Tom helps develop teams to create compliant processes and systems that deliver results to clients.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.